Our Mission: Highlighting Innovations by showcasing breakthroughs in cancer research, including diagnostic tools, therapies, and preventive measures.

New drug offers hope for hormone-resistant prostate cancer

A groundbreaking study has shown that a drug currently being tested for ovarian and bile duct cancer, called NXP800, could also help treat advanced prostate cancer that no longer responds to hormone therapy. Published in Clinical Cancer Research, the study highlights how NXP800 slows the growth of prostate cancer cells, even in cases resistant to standard […]

error: Content is protected !!